Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 0 | 1,570,049 | 1,658,516 | 1,340,471 | 1,357,288 |
| Cost of Goods | N/A | 800,860 | 834,167 | 741,345 | 692,158 |
| Gross Profit | 435,940 | 769,180 | 824,340 | 599,120 | 665,130 |
| Operating Expenses | 219,660 | 499,885 | 519,741 | 463,769 | 453,774 |
| Operating Income | -219,660 | 270,164 | 304,775 | 135,702 | 211,514 |
| Interest Expense | 0 | 6,376 | 4,290 | 3,510 | 2,133 |
| Other Income | 0 | 51,001 | 38,434 | 26,421 | 13,810 |
| Pre-tax Income | -219,660 | 314,789 | 338,919 | 158,613 | 223,191 |
| Income Tax | N/A | 101,089 | 149,851 | 48,506 | 66,501 |
| Net Income Continuous | -219,660 | 213,700 | 189,068 | 110,107 | 156,690 |
| Net Income Discontinuous | N/A | 0 | 948 | 0 | 0 |
| Net Income | $-219,660 | $213,700 | $190,016 | $110,107 | $156,690 |
| EBITDA(a) | $-156,350 | $337,084 | $374,495 | $222,682 | $304,844 |